BMS-538203HIV integrase inhibitor,highly efficient CAS# 543730-41-2 |
Related Products
- ITK inhibitor
Catalog No.:BCC1662
CAS No.:439574-61-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 543730-41-2 | SDF | Download SDF |
PubChem ID | 54706524 | Appearance | Powder |
Formula | C12H12FNO5 | M.Wt | 269.23 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : ≥ 54 mg/mL (200.57 mM); | ||
Chemical Name | (Z)-4-[(4-fluorophenyl)methyl-methoxyamino]-2-hydroxy-4-oxobut-2-enoic acid | ||
SMILES | CON(CC1=CC=C(C=C1)F)C(=O)C=C(C(=O)O)O | ||
Standard InChIKey | GACIOSIZKMLELV-POHAHGRESA-N | ||
Standard InChI | InChI=1S/C12H12FNO5/c1-19-14(11(16)6-10(15)12(17)18)7-8-2-4-9(13)5-3-8/h2-6,15H,7H2,1H3,(H,17,18)/b10-6- | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | BMS-538203 is a highly efficient HIV integrase inhibitor and antiviral agent.
IC50 value:
Target: HIV integrase
In the current study we demonstrate a hit-to-clinical candidate pathway that resulted in 50- and 2000-fold improvements in enzyme-inhibition and antiviral activity without an increase in molecular weight or change in molecular topology. The original hit , 1 (mw = 268) was optimized in a stepwise manner. Potential covalent protein-binding moieties were removed by reducing the number of the ketone groups. High enzyme inhibition activity was achieved by optimizing the aryl-portion of the molecule. Protein binding was reduced by replacing the standard amide by the corresponding methyl-hydroxamide. This eventually led to the discovery of BMS-538203 compound 2 (mw = 269) a highly efficient inhibitor and antiviral agent. References: |
BMS-538203 Dilution Calculator
BMS-538203 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.7143 mL | 18.5715 mL | 37.143 mL | 74.2859 mL | 92.8574 mL |
5 mM | 0.7429 mL | 3.7143 mL | 7.4286 mL | 14.8572 mL | 18.5715 mL |
10 mM | 0.3714 mL | 1.8571 mL | 3.7143 mL | 7.4286 mL | 9.2857 mL |
50 mM | 0.0743 mL | 0.3714 mL | 0.7429 mL | 1.4857 mL | 1.8571 mL |
100 mM | 0.0371 mL | 0.1857 mL | 0.3714 mL | 0.7429 mL | 0.9286 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
BMS-538203 is a highly efficient HIV integrase inhibitor and antiviral agent.
Featured Products
- 4'-Methoxyacetoacetanilide
Catalog No.:BCC8712
CAS No.:5437-98-9
- Decarine
Catalog No.:BCN5721
CAS No.:54354-62-0
- Eriodictyol 7,3'-dimethyl ether
Catalog No.:BCN8105
CAS No.:54352-60-2
- 4beta-Hydroxywithanolide E
Catalog No.:BCN7572
CAS No.:54334-04-2
- Protopseudohypericin
Catalog No.:BCN2813
CAS No.:54328-09-5
- Amsacrine hydrochloride
Catalog No.:BCC4310
CAS No.:54301-15-4
- Ac-Gly-OH
Catalog No.:BCC2943
CAS No.:543-24-8
- 2',4'-Dihydroxy-3',6'-dimethoxydihydrochalcone
Catalog No.:BCN1421
CAS No.:54299-52-4
- (+)-Fluprostenol
Catalog No.:BCC7947
CAS No.:54276-17-4
- Stachyose trihydrate
Catalog No.:BCN8361
CAS No.:54261-98-2
- 3-Benzoylpyridine
Catalog No.:BCC8623
CAS No.:5424-19-1
- Cimaterol
Catalog No.:BCC6647
CAS No.:54239-37-1
New Products
- 7-Hydroxy-5,8-dimethoxyflavanone
Catalog No.:BCN5722
CAS No.:54377-24-1
- N,N-Bis(2-hydroxyethyl)-p-phenylenediamine sulphate
Catalog No.:BCN8366
CAS No.:54381-16-7
- Lirinidine
Catalog No.:BCN8274
CAS No.:54383-28-7
- Palmitoylethanolamide
Catalog No.:BCC6828
CAS No.:544-31-0
- Myristic acid
Catalog No.:BCN8390
CAS No.:544-63-8
- Norcantharidin
Catalog No.:BCN1281
CAS No.:5442-12-6
- Capadenoson
Catalog No.:BCC1450
CAS No.:544417-40-5
- HIV-1 integrase inhibitor
Catalog No.:BCC1618
CAS No.:544467-07-4
- c-di-AMP
Catalog No.:BCC8054
CAS No.:54447-84-6
- MRS 1845
Catalog No.:BCC7198
CAS No.:544478-19-5
- UBP 282
Catalog No.:BCC7171
CAS No.:544697-47-4
- JNJ 10181457 dihydrochloride
Catalog No.:BCC7842
CAS No.:544707-20-2
BMS-538203 is a highly efficient HIV integrase inhibitor and antiviral agent.
BMS-538203,543730-41-2,Natural Products,HIV, buy BMS-538203 , BMS-538203 supplier , purchase BMS-538203 , BMS-538203 cost , BMS-538203 manufacturer , order BMS-538203 , high purity BMS-538203